During the upcoming UTECH Europe 2012 in Maastricht the business line Comfort & Insulation of Evonik Industries AG will highlight the following products on stand 1430:
Surfactants for Panel Systems
TEGOSTAB® B 8496 - is designed for use in PUR continuous metal panel systems to suppress void formation and achieve improved surface qualities.
TEGOSTAB® B 84503 - as PIR is getting more and more popular we developed this new silicone surfactant for PIR panel systems. It significantly improves the foam aesthetics.
TEGOSTAB® B 8485 - a widely applicable silicone surfactant that combines excellent flowability with top surface quality. Furthermore, this surfactant can offer advantages regarding shelf life stability of formic acid co-blown formulations.
TEGOSTAB® B 8155 - a new FR surfactant with medium activity for the full density range of conventional flexible slabstock foam. It provides excellent processing latitude and is well suited for CAL 117, MVSS 302 as well as BS 5852 Crib V formulations.
KOSMOS® 27 - our new innovative tin catalyst is the 2-Ethylhexanoic acid free alternative of the well known KOSMOS® 29. In the production process of polyether polyurethane foams KOSMOS® 27 acts as an efficient catalyst and accelerates the gelling reaction.
ORTEGOL® HPH 1 & ORTEGOL® HPH 2 - new additives to enhance the hydrophilicity of foam. These are relevant for all applications where water needs to penetrate into the flexible foam structure.
TEGOSTAB® B 8383 - our latest stabiliser for FR Ester Foam. It provides good stabilisation, fine cell structure in low densities and a broad processing latitude. It is suitable for flame lamination and all other kinds of ester foam applications. Additionally it has low VOC properties and is easily compatible with die cutting additives.
TEGOSTAB® B 8742 LF 2 – a silicone surfactant that has been proven to reduce transmissivity (A/A0) of vibration through HR TDI or TM20 seating foam and in that way improving passenger dynamic comfort. Easy foam crushability and wide processing latitude are maintained while meeting low VOC requirements.
Low VOC requirements
TEGOSTAB® B 8736 LF 2 – a silicone surfactant for TDI/TM20 HR Moulded Foam that offers a wide processing latitude, provides excellent cell regulation, a subsurface structure free of voids, open cell structure (i.e. easy-to-crush foam) and meets extra low VOC standards.
TEGOSTAB® B 8734 LF 2 - our MDI HR Moulded Foam surfactant which offers an excellent surface/subsurface regulation, open cell/easy to crush foam, very broad processing latitude and extra low VOC.
TEGOSTAB® B 8745 LF 2 - the newly developed silicone surfactant for MDI HR Moulded Foam that significantly enhances the MDI-system miscibility and fulfils extra low VOC needs.
Evonik offers GORAPUR® release agents from its affiliate Evonik Gorapur GmbH, Germany, to the market. The portfolio includes products for the automotive and shoe-sole-industry as well as many other polyurethane applications.
GORAPUR® LK 8516-10 B – an innovative catalyst free release agent for automotive seating applications.
GORAPUR® LI 1029-41 B – our new release agent for steering wheels with low VOC content, providing a very matte surface.
GORAPUR® LI 0245-8 B – a low VOC release agent for filter applications with excellent release properties.
GORAPUR® LS 1549-2 W – an interesting VOC-free water based release agent for PU shoe soles.
GORAPUR® CL 114 W – a unique external water based release agent for CLBS (continuous laminated board stocks systems) processing.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.